Prelude Therapeutics Incorporated Common Stock (PRLD)

Typically moves ±7.70% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-11-09 APPROXIMATE
search

Since Aug 12, 2021, Prelude Therapeutics Incorporated Common Stock (PRLD) has reported earnings 21 times. On average the shares move ±7.70% post-earnings, with a positive reaction 52.4% of the time. Its largest post-earnings gain was +32.71% (Feb 15, 2024) and its largest decline was -7.02% (Nov 14, 2022). The next earnings report is predicted for 2026-11-09 (approximate).

Earnings reactions

How PRLD moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

21

Avg Abs. Movement

±7.70%

Positive %

52.4%

Negative %

47.6%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 11, 2026 ☀ PRE +10.18% open_in_new
May 12, 2026 ☀ PRE -3.33% open_in_new
Mar 10, 2026 ☀ PRE +16.29% open_in_new
Nov 12, 2025 ☀ PRE +8.15% open_in_new
event

Earnings Count

21

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.70%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 16 →
16
Funds holding
$19222064
Total value held
Buying
13 added · 2 reduced
Blackrock, Inc.
$9580681 +458.43%
Morgan Stanley
$2685574 +56.40%
State Street Corp
$2285435 +210.20%
Ubs Group Ag
$1699188 NEW BUY
Northern Trust Corp
$1282393 +380.05%

Frequently asked about PRLD earnings

When does Prelude Therapeutics Incorporated Common Stock report earnings next? expand_more

Prelude Therapeutics Incorporated Common Stock (PRLD)'s next earnings date is approximate for 2026-11-09. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does PRLD stock move after earnings? expand_more

Over 21 reports, PRLD has moved an average of ±7.70% the session after earnings, closing higher 52.4% of the time.

What was PRLD's biggest post-earnings move? expand_more

PRLD's largest post-earnings gain on record was +32.71% on Feb 15, 2024, and its largest decline was -7.02% on Nov 14, 2022.

Where can I find Prelude Therapeutics Incorporated Common Stock's SEC filings? expand_more

All of Prelude Therapeutics Incorporated Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.